§ Funding Round
CRISPR Therapeutics raised $38M Series B Plus venture round.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|---|---|
Franklin Templeton | — | — |
| Organization | — | |
| Organization | — |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$127M
Top Valuation
-
CRISPR Therapeutics raised $38M in a Series B Plus round.
The round was announced on 06/24/16.
